Dexcom Reports First Quarter 2020 Financial Results

Go back to Dexcom Reports First Quarter 2020 Financial Results

DexCom (DXCM) Tops Q1 EPS by 30c; Withdraws Outlook

April 28, 2020 4:17 PM EDT

DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.44, $0.30 better than the analyst estimate of $0.14. Revenue for the quarter came in at $405.1 million versus the consensus estimate of $357.64 million.

Our strong first quarter results demonstrate the continued momentum in our business, driven by growing awareness and customer satisfaction with our G6 CGM technology. said Kevin Sayer,... More